Vimarsana
Biggest News Aggregation in the World

Page 4 - Randomized Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randomized Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randomized Clinical Today - Breaking & Trending Today

Study explores traditional Atlantic diets as a potential solution for diet-related diseases and environmental sustainability - Vimarsana News

Study explores traditional Atlantic diets as a potential solution for diet-related diseases and environmental sustainability

Researchers from Spain investigated the effect of a traditional Atlantic diet on health and the environment.

Artificial intelligence helps predict whether - Vimarsana News

Artificial intelligence helps predict whether

<p>In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work. With the help of an AI algorithm,&nbsp;a brain scan and an individual&#39;s clinical information, researchers from Amsterdam UMC and Radboudumc could see up to 8 weeks faster whether or not the medication would work. The results of this study are published today in the American Journal of Psychiatry.</p>

Alirocumab Reduces LDL-C in Pediatric Heterozygous Familial Hypercholesterolemia - Vimarsana News

Alirocumab Reduces LDL-C in Pediatric Heterozygous Familial Hypercholesterolemia

Alirocumab every 2 or 4 weeks significantly reduced LDL-C in pediatric patients with inadequately controlled heterozygous familial hypercholesterolemia.

False Positives: Common Drug Discovered To Interfere With Alzheimer's Blood Tests - Vimarsana News

False Positives: Common Drug Discovered To Interfere With Alzheimer's Blood Tests

Alzheimer's disease (AD) is linked to harmful protein accumulations in the brain, primarily β-amyloid (Aβ) aggregates known as plaques, which are central to the disease's pathology. Entresto (sacubitril/valsartan) is a combined neprilysin inhibitor and angiotensin receptor blocker, approved for the

Comparing perioperative differences: Sleeve gastrectomy vs. Roux-en-Y gastric bypass - Vimarsana News

Comparing perioperative differences: Sleeve gastrectomy vs. Roux-en-Y gastric bypass

Study compares laparoscopic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in obese patients, finding both procedures have low, comparable perioperative risks and complications, challenging the criteria for selecting between the two surgeries.